GLP‐1 receptor agonists and cardiovascular disease in patients with type 2 diabetes

MI del Olmo-Garcia… - Journal of diabetes …, 2018 - Wiley Online Library
Diabetes mellitus is a chronic disease prevalence of which is high and continually growing.
Cardiovascular disease continues to be the leading cause of death in patients with T2DM …

[HTML][HTML] The burden of disease in Spain: Results from the Global Burden of Disease 2016

JB Soriano, D Rojas-Rueda, J Alonso, JM Anto… - … Clínica (English Edition), 2018 - Elsevier
Background and objectives The global burden of disease (GBD) project measures the
health of populations worldwide on an annual basis, and results are available by country …

Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis

I Cavero-Redondo, A Saz-Lara… - Frontiers in …, 2023 - frontiersin.org
Aims: To synthesize and evaluate the available scientific evidence on the efficacy of
antihypertensive drugs on arterial stiffness in patients with hypertension by using a network …

Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial

V Arija, F Villalobos, R Pedret, A Vinuesa… - Health and quality of life …, 2018 - Springer
Background Physical activity (PA) promotes cardiovascular health and health related quality
of life (HRQoL), although the effect of that on blood pressure (BP) control has rarely been …

[HTML][HTML] La carga de enfermedad en España: resultados del Estudio de la Carga Global de las Enfermedades 2016

JB Soriano, D Rojas-Rueda, J Alonso, JM Antó… - Medicina clinica, 2018 - Elsevier
Antecedentes y objetivo El estudio de la carga global de las enfermedades, conocido como
GBD por sus siglas en inglés (global burden of disease), mide la salud poblacional en todo …

1991—2015 年中国成人高血压患病率, 知晓率, 治疗率, 控制率的变化趋势及其影响因素研究

姚溪, 裴晓婷, 曲哲 - 中国全科医学, 2022 - chinagp.net
背景高血压是我国常见的慢性非传染性疾病之一, 也是冠状动脉粥样硬化,
脑卒中等多种心脑血管疾病的危险因素. 近年来, 高血压患病率不断增高, 而治疗率和控制率却 …

Prevalence and factors associated with polypharmacy in the older people: 2006–2014

JM Carmona‐Torres, AI Cobo‐Cuenca… - Journal of clinical …, 2018 - Wiley Online Library
Aims and objectives To analyse the prevalence, risk factors and evolution over time of
polypharmacy and self‐medication in the older people in Spain from 2006–2014 …

Changes in hypertension prevalence, awareness, treatment and control rates over 20 years in National Capital Region of India: results from a repeat cross-sectional …

A Roy, PA Praveen, R Amarchand, L Ramakrishnan… - BMJ open, 2017 - bmjopen.bmj.com
Background and objectives Despite being one of the leading risk factors of cardiovascular
mortality, there are limited data on changes in hypertension burden and management from …

COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study

A Jurado, MC Martín, C Abad-Molina, A Orduña… - Immunity & …, 2020 - Springer
Abstract Background The SARS-CoV-2 infection has widely spread to become the greatest
public health challenge to date, the COVID-19 pandemic. Different fatality rates among …

Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients

J Buendía-Martínez, M Barreda-Sánchez… - Orphanet Journal of …, 2021 - Springer
Background Acute intermittent porphyria (AIP) is a genetic disease characterized by acute
neurovisceral attacks. Long-term clinical conditions, chronic symptoms and impaired health …